Part 3 Quiz Version - Sinoe medical homepage.

Cardiology – Part 3
Quiz
b) Intravenous (IV)
c) Intramuscular (IM)
d) Oral pill or spray (PO)
e) Intraosseous (IO)
19) Which of the following patients would NOT require extra precautions when
administering lidocaine
a) Patient with left ventricular (LV) heart failure
b) Patient taking propranolol (Inderal)
c) Patient taking cimetidine (Tagamet)
d) Patient with cirrhosis of the liver
e) Patient taking NSAIDs
20) A patient presents in pulseless cardiac arrest (VT/VF). Two defibrillation attempts
are made and a round of a vasopressor (epinephrine) is given via IV. As cardiopulmonary
resuscitation (CPR) continues, what drug could be given to help terminate the
arrhythmia
a) Adenosine (Adenocard)
b) Diltiazem (Cardiazem)
c) Flecainide (Tambocor)
d) Lidocaine (Xylocaine)
e) Esmolol (Brevibloc)
21) Flecainide and propafenone are effective in suppressing supraventricular arrhythmias.
Flecainide is also useful for suppressing which of the following
a) Premature ventricular contractions (PVCs)
b) Ventricular fibrillation (VF)
c) Torsade de Pointes (TdP)
d) Ventricular tachycardia (VT)
e) Ventricular asystole
22) Which of the following is a life-threatening adverse effect of flecainide and
propafenone
a) Metallic taste and constipation
b) Exacerbation of arrhythmia
c) Severe hyperkalemia
d) Hemolytic anemia
e) Watershed infarct
23) What was the result of the cardiac arrhythmia suppression trial (CAST), where
flecainide and encainide were used to suppress post-MI PVCs
a) Flecainide showed better total survival over encainide
b) Encainide showed better total survival over flecainide
c) Flecainide was not able to suppress post-MI PVCs
d) Encainide was not able to suppress post-MI PVCs
e) Both drugs led to increased mortality
24) What is the major cardiac effect of beta-blocking agents
a) Increased vascular resistance
b) Decreased right atrial preload
c) Increased left ventricular function
d) Decreased heart rate
Version: 16Oct2008 Page 14 of 60